Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2007
08/23/2007US20070197536 Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors
08/23/2007US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
08/23/2007US20070197513 calcium channel modulator; [[1-(4-{2-[1-(4-Chloro-phenyl)-2-(2-methoxy-phenyl)-1H-imidazol-4-yl]-ethyl}-(4-fluoro-phenyl)-methyl-amine; analgesic, antidiabetic agent; angina, hypertension, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
08/23/2007US20070197504 tert-butyl 4-{[3-({[(6-methyl-3-pyridyl)amino]carbonylamino}methyl)phenyl]methyl}-piperazinecarboxylate; selectively modulates the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure
08/23/2007US20070197492 Modulation of Pathogenicity
08/23/2007US20070197482 Regulation of guanine nucleotide exchange factor for a protein belonging to the rap family of small gtpases
08/23/2007US20070197472 N-Alkynyl-2-Heteroaryloxyalkylamides For Use As Fungicides
08/23/2007CA2642738A1 Pi-3 kinase inhibitors and methods of their use
08/23/2007CA2642483A1 Heterocyclic antiviral compounds
08/23/2007CA2641766A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
08/23/2007CA2641734A1 Acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
08/23/2007CA2641673A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
08/23/2007CA2640807A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
08/23/2007CA2640582A1 Pyridine-2-, pyrimidine-2-carboxamide derivatives
08/23/2007CA2640307A1 Pesticides containing a bicyclic bisamide structure
08/23/2007CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
08/23/2007CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
08/22/2007EP1819701A1 Cyclic iminocarbamates and use thereof
08/22/2007EP1819695A1 Anthranilamide derivatives as insecticides
08/22/2007EP1819691A2 Biaryloxymethylarene carboxylic acids
08/22/2007EP1819341A2 Il-12 modulatory compounds
08/22/2007EP1720870B1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/22/2007EP1615919B1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
08/22/2007EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/22/2007EP1300399B1 Phenylpyridazine derivatives and drugs containing the same
08/22/2007EP1150980B1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/22/2007CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/22/2007CN1332954C Dipeptidyl peptidase IV effectors
08/22/2007CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
08/22/2007CN101023080A Thiazolinone 4-monosubstituted quinolines
08/22/2007CN101023079A Substituted hydantoins for the treatment of cancer
08/22/2007CN101023073A Heteroaroyl-substituted serine amides utilized as herbicides
08/22/2007CN101023072A Piperidinyl targeting compounds that selectively bind integrins
08/22/2007CN101020687A New thiobizole formanide derivative and its synthesis process and bioactivity
08/22/2007CN101020667A New compound with activity of inducing secondary metabolism of Hypericum plant
08/21/2007US7259262 Arylazole derivatives, their manufacture and use as pharmaceutical agents
08/21/2007US7259182 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders
08/21/2007US7259176 Process for the preparation of the insulin sensitizer
08/21/2007US7259175 Alkanoic acids substituted with a group containing pyridinyl-, pyrimidinyl- or pyrazinyl-phenyl linked through a thiazolyl- or oxazolyl- phenyl group; e.g., 3-[4-(2-{2-[6-(2-Fluoro-phenyl)-pyridin-3-yl]-5-methyl-thiazol-4-yl}-ethoxy)-2-methyl-phenyl]-propionic acid; treating diabetes and atherosclerosis
08/21/2007US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
08/21/2007US7259163 Viricides against herpes virus
08/21/2007US7259162 Benzazole derivatives and their use as JNK modulators
08/21/2007US7259158 Naphthaline derivatives as H3 inverse agonists
08/21/2007US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
08/21/2007CA2397270C Method for the preparation of 5-cyanophthalide
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/21/2007CA2237348C Process for preparing 2-chlorothiazole compounds
08/16/2007WO2007092751A2 Compounds and methods for modulating fx-receptors
08/16/2007WO2007091736A1 Novel coumarin derivative having antitumor activity
08/16/2007WO2007091622A1 Anti-cancer pharmaceutical composition
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate
08/16/2007WO2007076460A3 Substituted thiazole ureas useful as inhibitors of protein kinases
08/16/2007WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
08/16/2007WO2007026959A3 Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders
08/16/2007WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus
08/16/2007US20070191611 Comprising reacting a thiazolidine 2,4 dione and an intermediate metabisulphite complex of 4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzaldehyde; for treatment of non-insulin dependent diabetes mellitus
08/16/2007US20070191604 Novel compounds that are ERK inhibitors
08/16/2007US20070191435 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
08/16/2007US20070191429 Ppar activators
08/16/2007US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
08/16/2007US20070191423 Isoquinoline derivatives
08/16/2007US20070191413 Novel heterocycle-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
08/16/2007US20070191390 Substituted heterocyclic compounds
08/16/2007US20070191385 4-(O-(2-(biphenylmethyl)-4-phenylimidazol-1-yl)phenyl)-1,2,5-thiadiazolidine-3-one derivatives; used to treat type I and type II diabetes
08/16/2007US20070191383 Mtp inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
08/16/2007US20070191353 Use of thiadiazoleurea derivatives
08/16/2007US20070191346 3-Cyano-quinoline derivatives
08/16/2007US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
08/16/2007US20070191341 N-Substituted Benzene Sulfonamides
08/16/2007US20070190634 Compositions useful as inhibitors of protein kinases
08/16/2007US20070189987 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof
08/16/2007US20070189967 a mixture of a benzofuran derivatives such as [2-(2-formyl-5-furanyl)-3-hydroxymethyl benzofuran], and a label selected from radioisotopes, paramagnetic particles and optical particles, used for in vivo and in vitro detection beta-amyloid in a sample of brain tissues; noninvasive medical diagnosis
08/16/2007US20070189865 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
08/16/2007CA2651987A1 Piperidinyl derivatives as modulators of chemokine receptor activity
08/16/2007CA2642665A1 Anti-cancer pharmaceutical composition
08/16/2007CA2640652A1 Novel coumarin derivative having antitumor activity
08/16/2007CA2640476A1 Compounds and methods for modulating fx-receptors
08/16/2007CA2637768A1 Benzamide and heteroarene derivatives
08/15/2007EP1818334A1 Anti-trypanosomiasis agent
08/15/2007EP1818333A1 Vanilloid receptor ligands and their use in treatments
08/15/2007EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds
08/15/2007EP1817806A1 Phenothazines, -s-oxides, and s,s-dioxides as well as phenoxazines as emitters for oleds
08/15/2007EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors
08/15/2007EP1817285A2 Cycloalkyl keto piperidine tachykinin receptor antagonists
08/15/2007EP1817030A2 Inducible nitric oxide synthase dimerization inhibitors
08/15/2007EP1523533B1 Luminescent compositions
08/15/2007EP1480640B1 Peroxisome proliferator activated receptor modulators
08/15/2007EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists
08/15/2007EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
08/15/2007EP1440069B1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
08/15/2007EP1437349B1 Substituted isoxazoles and the use thereof as antibiotics
08/15/2007EP1354879B1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/15/2007CN1331853C Small molecule inhibitors of rotamase enzyme activity
08/15/2007CN101018785A Thiazolinone 2-substituted quinolines
08/15/2007CN101018782A Hydantoin compound for the treatment of inflammatory disorders
08/15/2007CN101018773A Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes.